| Literature DB >> 23031425 |
Emre Özker1, Bülent Saritaş, Can Vuran, Uygar Yörüker, Halim Ulugöl, Riza Türköz.
Abstract
BACKGROUND: Delayed sternal closure (DSC) after cardiac surgery is a therapeutic option in the treatment of the severely impaired heart in pediatric cardiac surgery. The results with the technique of DSC over a 4-year period are examined with regard to mortality and morbidity.Entities:
Mesh:
Substances:
Year: 2012 PMID: 23031425 PMCID: PMC3514162 DOI: 10.1186/1749-8090-7-102
Source DB: PubMed Journal: J Cardiothorac Surg ISSN: 1749-8090 Impact factor: 1.637
The diagnosis and distribution of the exitus
| HLHS | 7 | 7 |
| TGA | 9 | - |
| TGA + VSD | 10 | - |
| CAVSD | 1 | - |
| CAVSD + TA | 1 | 1 |
| TAPVC | 4 | 2 |
| TOF | 1 | 1 |
| DORV | 1 | 1 |
| AO INTER | 1 | - |
| VSD | 3 | 1 |
Table 1 demonstrating the cardiac pathologies of the patients. (HLHS: Hypoplastic Left Heart Syndrome; TGA: Transposition of Great Arteries; VSD: Ventricular Septal Defect; CAVSD: Complete Atrioventricular Septal Defect;TA: Tricuspid Atresia; TAPVC: Total Anomalous Pulmonary Vein Connection; TOF: Tetralogy Of Fallot; DORV: Double Outlet Right Ventricle; AO INTER: Aortic Interruption).
Postoperative infection data
| 1. | VSD | Blood | Staf A | EX |
| 2. | HLHS | Blood | Klebs P | EX(LCO) |
| 3. | HLHS | Blood | Staf A | EX |
| 4. | HLHS | Blood | Enterococ A,Staf A | EX |
| 5. | TOF | Blood | Klebs P,Staf A | EX |
| 6. | HLHS | Blood | VRE, Candida A | EX (LCO) |
| 7. | TAPVC | Blood | Acinetobac | EX |
| 8. | TAPVC | Blood | Staf A,Candida A | EX |
| 9. | HLHS | Blood | Candida A, Acinetobac,VRE | EX |
| 10. | TGA | Sputum | Candida A | |
| 11. | TGA | Blood | VRE | |
| 12. | TGA | Sternum(SWI) | SWI | |
| 13. | TGA | Sternum(SWI) | SWI | |
| 14. | CAVSD | Sputum | Acinetobac | |
| 15. | TGA + VSD | Sternum(SWI) | SWI | |
| 16. | TGA + VSD | Sternum | Enterobact A | |
| 17. | TGA | Blood/Sternum (SWI) | Candida A | |
| 18. | TGA | Sputum | Acinetobac | |
| 19. | TGA | Blood/Urinary inf | Staf A/Enterobact A | |
| 20. | VSD | Sternum(SWI) | SWI | |
| 21. | TGA + VSD | Sternum | Klebs P | |
| 22. | AO INTER | Blood | Klebs P | |
| 23. | TGA + VSD | Sternum | Enterobact A | |
| 24. | TGA | Blood | Klebs P,Pseudomonas A | |
| 25. | TGA | Urinary inf/Sternum(SWI) | Klebs P | |
| 26. | TAPVC | Blood/Sputum | Staf A/Pseudomonas A | |
| 27. | TGA + VSD | Sputum | Pseudomonas A | |
| 28. | TGA + VSD | Blood | Enterobact A | |
| 30. | TGA + VSD | Sternum | Staf A |
Table 2 showing site of infection and the detected organisms with the clinical outcome after treatment. (Urinary inf: Urinary infection; Staf A: Stafilococcus Aureus; Klebs P: Klebsiella Pneumonia; Enterococ A: Enterococcus Aeruginosa; VRE: Vancomycin resistant Enterococcus; Acinetobac: Acinetobacter; Enterobact A: Enterobacter Aerogenes; Candida A: Candida Albicans; SWI: Sterile wound infection; Pseudomonas A: Pseudomonas Aeruginosa;EX: Exitus); LCO: Low cardiac output.